Puliginurad
CAS No. 2013582-27-7
Puliginurad( —— )
Catalog No. M35505 CAS No. 2013582-27-7
Puliginurad (YL-90148) is a potent and selective inhibitor of the urate transporter protein (URAT), effectively inhibiting uric acid reabsorption. It can be utilized for the prevention and treatment of hyperuricemia and gout.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | Get Quote |
|
| 5MG | 140 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePuliginurad
-
NoteResearch use only, not for human use.
-
Brief DescriptionPuliginurad (YL-90148) is a potent and selective inhibitor of the urate transporter protein (URAT), effectively inhibiting uric acid reabsorption. It can be utilized for the prevention and treatment of hyperuricemia and gout.
-
DescriptionPuliginurad (YL-90148) is a potent urate transporter (URAT) inhibitor. Puliginurad can be used for hyperuricemia and gout research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOAT
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2013582-27-7
-
Formula Weight336.41
-
Molecular FormulaC19H16N2O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 130 mg/mL (386.43 mM; Ultrasonic )
-
SMILESC(C(C(O)=O)(C)C)C1=CC2=C(C=NC=C2S1)C3=CC=C(C#N)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. WHO Drug Information. International Nonproprietary Names for Pharmaceutical
molnova catalog
related products
-
8-Methyl Chrysophano...
8-Methyl Chrysophanol is an anthraquinone isolated from the bark of?Senna macranth.
-
H-Cys-Ser-Arg-Ala-Ar...
PA22-2 (free acid) (Cys-Laminin A chain 2091-2108) is a peptide that supports neurite outgrowth and stimulates neuronal-like process formation. PA22-2 (free acid) can be used to culture human adenoid cystic carcinoma cells, and in the preparation of peptide-functionalized supported phospholipid bilayers.
-
DL-Pyroglutamic acid
DL-Pyroglutamic acid exhibited a strong inactivating effect on hepatitis B surface antigen.?
Cart
sales@molnova.com